235 related articles for article (PubMed ID: 22997248)
1. Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy.
Li J; Kritzer MD; Michel JJ; Le A; Thakur H; Gayanilo M; Passariello CL; Negro A; Danial JB; Oskouei B; Sanders M; Hare JM; Hanauer A; Dodge-Kafka K; Kapiloff MS
Circ Res; 2013 Jan; 112(1):128-39. PubMed ID: 22997248
[TBL] [Abstract][Full Text] [Related]
2. Signalosome-Regulated Serum Response Factor Phosphorylation Determining Myocyte Growth in Width Versus Length as a Therapeutic Target for Heart Failure.
Li J; Tan Y; Passariello CL; Martinez EC; Kritzer MD; Li X; Li X; Li Y; Yu Q; Ohgi K; Thakur H; MacArthur JW; Ivey JR; Woo YJ; Emter CA; Dodge-Kafka K; Rosenfeld MG; Kapiloff MS
Circulation; 2020 Dec; 142(22):2138-2154. PubMed ID: 32933333
[TBL] [Abstract][Full Text] [Related]
3. RSK3: A regulator of pathological cardiac remodeling.
Martinez EC; Passariello CL; Li J; Matheson CJ; Dodge-Kafka K; Reigan P; Kapiloff MS
IUBMB Life; 2015 May; 67(5):331-7. PubMed ID: 25988524
[TBL] [Abstract][Full Text] [Related]
4. p90 ribosomal S6 kinase 3 contributes to cardiac insufficiency in α-tropomyosin Glu180Gly transgenic mice.
Passariello CL; Gayanilo M; Kritzer MD; Thakur H; Cozacov Z; Rusconi F; Wieczorek D; Sanders M; Li J; Kapiloff MS
Am J Physiol Heart Circ Physiol; 2013 Oct; 305(7):H1010-9. PubMed ID: 23913705
[TBL] [Abstract][Full Text] [Related]
5. RSK3 is required for concentric myocyte hypertrophy in an activated Raf1 model for Noonan syndrome.
Passariello CL; Martinez EC; Thakur H; Cesareo M; Li J; Kapiloff MS
J Mol Cell Cardiol; 2016 Apr; 93():98-105. PubMed ID: 26940993
[TBL] [Abstract][Full Text] [Related]
6. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
[TBL] [Abstract][Full Text] [Related]
7. Calcineurin Aβ-Specific Anchoring Confers Isoform-Specific Compartmentation and Function in Pathological Cardiac Myocyte Hypertrophy.
Li X; Li J; Martinez EC; Froese A; Passariello CL; Henshaw K; Rusconi F; Li Y; Yu Q; Thakur H; Nikolaev VO; Kapiloff MS
Circulation; 2020 Sep; 142(10):948-962. PubMed ID: 32611257
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of p90 ribosomal S6 kinase (RSK) regulates extracellular signal-regulated kinase docking and RSK activity.
Roux PP; Richards SA; Blenis J
Mol Cell Biol; 2003 Jul; 23(14):4796-804. PubMed ID: 12832467
[TBL] [Abstract][Full Text] [Related]
9. Cardiac Hypertrophy Is Inhibited by a Local Pool of cAMP Regulated by Phosphodiesterase 2.
Zoccarato A; Surdo NC; Aronsen JM; Fields LA; Mancuso L; Dodoni G; Stangherlin A; Livie C; Jiang H; Sin YY; Gesellchen F; Terrin A; Baillie GS; Nicklin SA; Graham D; Szabo-Fresnais N; Krall J; Vandeput F; Movsesian M; Furlan L; Corsetti V; Hamilton G; Lefkimmiatis K; Sjaastad I; Zaccolo M
Circ Res; 2015 Sep; 117(8):707-19. PubMed ID: 26243800
[TBL] [Abstract][Full Text] [Related]
10. Empagliflozin mitigates cardiac hypertrophy through cardiac RSK/NHE-1 inhibition.
Chen S; Overberg K; Ghouse Z; Hollmann MW; Weber NC; Coronel R; Zuurbier CJ
Biomed Pharmacother; 2024 May; 174():116477. PubMed ID: 38522235
[TBL] [Abstract][Full Text] [Related]
11. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-Converting Enzyme 3 (ACE3) Protects Against Pressure Overload-Induced Cardiac Hypertrophy.
Yu CJ; Tang LL; Liang C; Chen X; Song SY; Ding XQ; Zhang KY; Song BL; Zhao D; Zhu XY; Li HL; Zhang ZR
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26892527
[TBL] [Abstract][Full Text] [Related]
13. Targeted deletion of the extracellular signal-regulated protein kinase 5 attenuates hypertrophic response and promotes pressure overload-induced apoptosis in the heart.
Kimura TE; Jin J; Zi M; Prehar S; Liu W; Oceandy D; Abe J; Neyses L; Weston AH; Cartwright EJ; Wang X
Circ Res; 2010 Mar; 106(5):961-70. PubMed ID: 20075332
[TBL] [Abstract][Full Text] [Related]
14. BMP type I receptor ALK2 is required for angiotensin II-induced cardiac hypertrophy.
Shahid M; Spagnolli E; Ernande L; Thoonen R; Kolodziej SA; Leyton PA; Cheng J; Tainsh RE; Mayeur C; Rhee DK; Wu MX; Scherrer-Crosbie M; Buys ES; Zapol WM; Bloch KD; Bloch DB
Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H984-94. PubMed ID: 26873969
[TBL] [Abstract][Full Text] [Related]
15. H-Ras Isoform Mediates Protection Against Pressure Overload-Induced Cardiac Dysfunction in Part Through Activation of AKT.
Matsuda T; Jeong JI; Ikeda S; Yamamoto T; Gao S; Babu GJ; Zhai P; Del Re DP
Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28193718
[TBL] [Abstract][Full Text] [Related]
16. RSK3 mediates necroptosis by regulating phosphorylation of RIP3 in rat retinal ganglion cells.
Wang M; Wan H; Wang S; Liao L; Huang Y; Guo L; Liu F; Shang L; Huang J; Ji D; Xia X; Jiang B; Chen D; Xiong K
J Anat; 2020 Jul; 237(1):29-47. PubMed ID: 32162697
[TBL] [Abstract][Full Text] [Related]
17. Regulation and interaction of pp90(rsk) isoforms with mitogen-activated protein kinases.
Zhao Y; Bjorbaek C; Moller DE
J Biol Chem; 1996 Nov; 271(47):29773-9. PubMed ID: 8939914
[TBL] [Abstract][Full Text] [Related]
18. A-kinase anchoring protein Lbc coordinates a p38 activating signaling complex controlling compensatory cardiac hypertrophy.
Pérez López I; Cariolato L; Maric D; Gillet L; Abriel H; Diviani D
Mol Cell Biol; 2013 Aug; 33(15):2903-17. PubMed ID: 23716597
[TBL] [Abstract][Full Text] [Related]
19. NADPH oxidase-4 promotes eccentric cardiac hypertrophy in response to volume overload.
Schnelle M; Sawyer I; Anilkumar N; Mohamed BA; Richards DA; Toischer K; Zhang M; Catibog N; Sawyer G; Mongue-Din H; Schröder K; Hasenfuss G; Shah AM
Cardiovasc Res; 2021 Jan; 117(1):178-187. PubMed ID: 31821410
[TBL] [Abstract][Full Text] [Related]
20. Loss of AKAP150 promotes pathological remodelling and heart failure propensity by disrupting calcium cycling and contractile reserve.
Li L; Li J; Drum BM; Chen Y; Yin H; Guo X; Luckey SW; Gilbert ML; McKnight GS; Scott JD; Santana LF; Liu Q
Cardiovasc Res; 2017 Feb; 113(2):147-159. PubMed ID: 27856611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
